Related Experiment Video
Updated: Nov 19, 2025

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Refractory Kawasaki Disease-a Challenge for the Pediatrician
Deepu Abraham1, Sridhar Kalyanasundaram2, Kandamaran Krishnamurthy3
1Zulekha Hospital, Dubai, United Arab Emirates.
Insights
Kawasaki disease (KD) is a childhood illness causing artery inflammation, particularly in coronary arteries. This overview focuses on difficult-to-treat KD cases and their alternative therapeutic strategies.
Area of Science:
- Pediatrics
- Cardiology
- Rheumatology
Background:
- Kawasaki disease (KD) is an acute, self-limiting febrile illness in children.
- It is characterized by vasculitis, primarily affecting medium-sized arteries, with significant implications for coronary arteries.
- While classic KD has defined criteria, atypical presentations are common and challenging for clinicians.
Purpose of the Study:
- To provide an overview of Kawasaki disease.
- To specifically address refractory or treatment-resistant cases of KD.
- To discuss available treatment options for resistant Kawasaki disease.
Main Methods:
- Literature review of Kawasaki disease.
- Focus on clinical presentation and diagnostic criteria.
- Analysis of treatment strategies for resistant cases.
Main Results:
- Most KD cases respond to standard treatment (intravenous immunoglobulin and aspirin).
- A subset of patients exhibit resistance to initial therapy.
- Alternative treatments are necessary for these refractory cases.
Conclusions:
- Kawasaki disease requires careful diagnosis, including recognition of atypical forms.
- Refractory KD presents a clinical challenge requiring consideration of alternative therapies.
- Management of resistant Kawasaki disease is crucial to prevent long-term complications.
Abstract:
Kawasaki disease (KD) is an acute, self-limiting febrile illness of childhood associated with vasculitis, mainly of the medium-sized arteries. The clinical significance and impact of this condition arise from its predilection for the coronary arteries. The criteria for classic Kawasaki disease are clearly defined, but many children present with atypical forms, and clinicians need to consider this possibility. Although most diagnosed cases respond to intravenous immunoglobulin (IVIG) and aspirin, some have proven resistant to the standard treatment. This article aims to provide a brief overview of Kawasaki disease, focusing on the resistant/refractory cases, and the treatment options available for such cases.
More Related Videos
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Rheumatic Heart Disease III: Medical Management
Mitral Stenosis III: Medical Management
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Chronic Kidney Disease III: Interprofessional Care
Pericarditis III: Medical Management

